Boomerang Medical’s IBD Neuromodulation Study Successfully Completes Enrollment Milestone

Boomerang Medical, Inc., a women-led bioelectronic medicine company focused on autoimmune diseases, proudly announced the completion of Stage 2 of its FDA-approved pilot study.

Scroll to Top